GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » CareMax Inc (NAS:CMAX) » Definitions » ROE %

CareMax (CareMax) ROE % : -635.79% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is CareMax ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. CareMax's annualized net income for the quarter that ended in Dec. 2023 was $-1,863.1 Mil. CareMax's average Total Stockholders Equity over the quarter that ended in Dec. 2023 was $293.0 Mil. Therefore, CareMax's annualized ROE % for the quarter that ended in Dec. 2023 was -635.79%.

The historical rank and industry rank for CareMax's ROE % or its related term are showing as below:

CMAX' s ROE % Range Over the Past 10 Years
Min: -200.69   Med: -4.67   Max: 112.99
Current: -144.17

During the past 4 years, CareMax's highest ROE % was 112.99%. The lowest was -200.69%. And the median was -4.67%.

CMAX's ROE % is ranked worse than
92.97% of 612 companies
in the Healthcare Providers & Services industry
Industry Median: 4.115 vs CMAX: -144.17

CareMax ROE % Historical Data

The historical data trend for CareMax's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CareMax ROE % Chart

CareMax Annual Data
Trend Dec20 Dec21 Dec22 Dec23
ROE %
112.99 -2.61 -6.72 -200.69

CareMax Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.67 -56.64 -22.25 -71.79 -635.79

Competitive Comparison of CareMax's ROE %

For the Health Information Services subindustry, CareMax's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CareMax's ROE % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, CareMax's ROE % distribution charts can be found below:

* The bar in red indicates where CareMax's ROE % falls into.



CareMax ROE % Calculation

CareMax's annualized ROE % for the fiscal year that ended in Dec. 2023 is calculated as

ROE %=Net Income (A: Dec. 2023 )/( (Total Stockholders Equity (A: Dec. 2022 )+Total Stockholders Equity (A: Dec. 2023 ))/ count )
=-683.348/( (619.547+61.444)/ 2 )
=-683.348/340.4955
=-200.69 %

CareMax's annualized ROE % for the quarter that ended in Dec. 2023 is calculated as

ROE %=Net Income (Q: Dec. 2023 )/( (Total Stockholders Equity (Q: Sep. 2023 )+Total Stockholders Equity (Q: Dec. 2023 ))/ count )
=-1863.068/( (524.616+61.444)/ 2 )
=-1863.068/293.03
=-635.79 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Dec. 2023) net income data. ROE % is displayed in the 30-year financial page.


CareMax  (NAS:CMAX) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=-1863.068/293.03
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-1863.068 / 607.34)*(607.34 / 840.709)*(840.709 / 293.03)
=Net Margin %*Asset Turnover*Equity Multiplier
=-306.76 %*0.7224*2.869
=ROA %*Equity Multiplier
=-221.6 %*2.869
=-635.79 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=-1863.068/293.03
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-1863.068 / -1868.652) * (-1868.652 / -335.232) * (-335.232 / 607.34) * (607.34 / 840.709) * (840.709 / 293.03)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.997 * 5.5742 * -55.2 % * 0.7224 * 2.869
=-635.79 %

Note: The net income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


CareMax ROE % Related Terms

Thank you for viewing the detailed overview of CareMax's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


CareMax (CareMax) Business Description

Traded in Other Exchanges
N/A
Address
1000 NW 57th Court, Suite 400, Miami, FL, USA, 33126
CareMax Inc is a technology-enabled care platform providing value-based care and chronic disease management to seniors. It operates various owned medical centers that offer a comprehensive suite of healthcare and social services and a proprietary software and services platform that provides data, analytics, and rules-based decision tools/workflows for physicians across the United States.
Executives
Bryan Cho director 30 HUDSON YARDS, 72ND FLOOR, NEW YORK NY 10001
De La Torre Ralph director, 10 percent owner 4939 BROOKVIEW DRIVE, DALLAS TX 75220
Ryan Oquinn director 1000 NW 57 COURT, SUITE 400, MIAMI FL 33126
Kevin Berg director 345 PARK AVENUE SOUTH, 12TH FLOOR, NEW YORK NY 10010
Beatriz Maria Assapimonwait director 1000 NW 57 CT., SUITE 400, MIAMI FL 33126
Vincent Omachonu director 1000 NW 57 CT., SUITE 400, MIAMI FL 33126
Jose Ramon Rodriguez director PRIMORIS SERVICES CORPORATION, 2300 NORTH FIELD STREET, SUITE 1900, DALLAS TX 75201
Related Cm Advisor, Llc director 30 HUDSON YARDS, 72ND FLOOR, NEW YORK NY 10001
Imc Holdings, Lp 10 percent owner 525 OKEECHOBEE BOULEVARD, SUITE 1050, WEST PALM BEACH FL 33401
William C. Lamoreaux officer: EVP 1000 NW 57 CT., SUITE 400, MIAMI FL 33126
Kevin Wirges officer: EVP, Treasurer and CFO 1000 NW 57 CT., SUITE 400, MIAMI FL 33126
De Solo Carlos A. director, officer: President and CEO 1000 NW 57 CT., SUITE 400, MIAMI FL 33126
Randy Simpson director C/O GLENVIEW CAPITAL MANAGEMENT, LLC, 767 FIFTH AVENUE, 44TH FLOOR, NEW YORK NY 10153
Solo Alberto De officer: EVP and COO 1000 NW 57 CT., SUITE 400, MIAMI FL 33126
Jennifer L. Carter director C/O DFP SPONSOR LLC, 780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017